PRE-SATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pre-sate, and when can generic versions of Pre-sate launch?
Pre-sate is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in PRE-SATE is chlorphentermine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the chlorphentermine hydrochloride profile page.
Summary for PRE-SATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Patent Applications: | 54 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PRE-SATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PRE-SATE
US Patents and Regulatory Information for PRE-SATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | PRE-SATE | chlorphentermine hydrochloride | TABLET;ORAL | 014696-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |